Global Immuno Cell Therapy Market Research Report 2025(Status and Outlook)
Report Overview
Immuno cell therapy represents a cutting-edge segment of the biopharmaceutical industry, focusing on harnessing the body's immune system to target and eliminate diseases, particularly cancers and autoimmune disorders. This therapy involves modifying a patient's immune cells?such as T cells, NK cells, or dendritic cells?to enhance their ability to recognize and attack malignant or dysfunctional cells. Key modalities include CAR-T (chimeric antigen receptor T-cell) therapy, TCR (T cell receptor) therapy, and tumor-infiltrating lymphocyte (TIL) therapy, each leveraging different mechanisms to induce immune responses. The market has seen rapid growth due to breakthroughs in genetic engineering, increased investment in R&D, and regulatory approvals for treatments targeting hematologic malignancies. However, challenges such as high manufacturing costs, complex logistics, and limited efficacy in solid tumors remain significant barriers. The competitive landscape features both established biotech firms and emerging players, with partnerships and acquisitions driving innovation. Geographically, North America leads in adoption, followed by Europe and Asia-Pacific, where regulatory frameworks and healthcare infrastructure are evolving to support advanced therapies. Future expansion hinges on overcoming technical hurdles, improving accessibility, and demonstrating long-term clinical benefits.
The global Immuno Cell Therapy market size was estimated at USD 2971.66 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.23% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immuno Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immuno Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immuno Cell Therapy market.
Global Immuno Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Segmentation (by Type)
Passive Immune (NK, LAK etc)
Active Immune
Market Segmentation (by Application)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno Cell Therapy Market
Overview of the regional outlook of the Immuno Cell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Immuno cell therapy represents a cutting-edge segment of the biopharmaceutical industry, focusing on harnessing the body's immune system to target and eliminate diseases, particularly cancers and autoimmune disorders. This therapy involves modifying a patient's immune cells?such as T cells, NK cells, or dendritic cells?to enhance their ability to recognize and attack malignant or dysfunctional cells. Key modalities include CAR-T (chimeric antigen receptor T-cell) therapy, TCR (T cell receptor) therapy, and tumor-infiltrating lymphocyte (TIL) therapy, each leveraging different mechanisms to induce immune responses. The market has seen rapid growth due to breakthroughs in genetic engineering, increased investment in R&D, and regulatory approvals for treatments targeting hematologic malignancies. However, challenges such as high manufacturing costs, complex logistics, and limited efficacy in solid tumors remain significant barriers. The competitive landscape features both established biotech firms and emerging players, with partnerships and acquisitions driving innovation. Geographically, North America leads in adoption, followed by Europe and Asia-Pacific, where regulatory frameworks and healthcare infrastructure are evolving to support advanced therapies. Future expansion hinges on overcoming technical hurdles, improving accessibility, and demonstrating long-term clinical benefits.
The global Immuno Cell Therapy market size was estimated at USD 2971.66 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.23% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immuno Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immuno Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immuno Cell Therapy market.
Global Immuno Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Segmentation (by Type)
Passive Immune (NK, LAK etc)
Active Immune
Market Segmentation (by Application)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno Cell Therapy Market
Overview of the regional outlook of the Immuno Cell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immuno Cell Therapy
1.2 Key Market Segments
1.2.1 Immuno Cell Therapy Segment by Type
1.2.2 Immuno Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Immuno Cell Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immuno Cell Therapy Product Life Cycle
3.3 Global Immuno Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immuno Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immuno Cell Therapy Market Competitive Situation and Trends
3.8.1 Immuno Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNO CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immuno Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNO CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immuno Cell Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Immuno Cell Therapy Price by Type (2020-2025)
7 IMMUNO CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno Cell Therapy Market Sales by Application (2020-2025)
7.3 Global Immuno Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNO CELL THERAPY MARKET SALES BY REGION
8.1 Global Immuno Cell Therapy Sales by Region
8.1.1 Global Immuno Cell Therapy Sales by Region
8.1.2 Global Immuno Cell Therapy Sales Market Share by Region
8.2 Global Immuno Cell Therapy Market Size by Region
8.2.1 Global Immuno Cell Therapy Market Size by Region
8.2.2 Global Immuno Cell Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Immuno Cell Therapy Sales by Country
8.3.2 North America Immuno Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immuno Cell Therapy Sales by Country
8.4.2 Europe Immuno Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immuno Cell Therapy Sales by Region
8.5.2 Asia Pacific Immuno Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immuno Cell Therapy Sales by Country
8.6.2 South America Immuno Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immuno Cell Therapy Sales by Region
8.7.2 Middle East and Africa Immuno Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNO CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immuno Cell Therapy by Region(2020-2025)
9.2 Global Immuno Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immuno Cell Therapy Production
9.4.1 North America Immuno Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immuno Cell Therapy Production
9.5.1 Europe Immuno Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immuno Cell Therapy Production (2020-2025)
9.6.1 Japan Immuno Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immuno Cell Therapy Production (2020-2025)
9.7.1 China Immuno Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 MEDINET Co
10.1.1 MEDINET Co Basic Information
10.1.2 MEDINET Co Immuno Cell Therapy Product Overview
10.1.3 MEDINET Co Immuno Cell Therapy Product Market Performance
10.1.4 MEDINET Co Business Overview
10.1.5 MEDINET Co SWOT Analysis
10.1.6 MEDINET Co Recent Developments
10.2 Erytech
10.2.1 Erytech Basic Information
10.2.2 Erytech Immuno Cell Therapy Product Overview
10.2.3 Erytech Immuno Cell Therapy Product Market Performance
10.2.4 Erytech Business Overview
10.2.5 Erytech SWOT Analysis
10.2.6 Erytech Recent Developments
10.3 Seta Clinic Group
10.3.1 Seta Clinic Group Basic Information
10.3.2 Seta Clinic Group Immuno Cell Therapy Product Overview
10.3.3 Seta Clinic Group Immuno Cell Therapy Product Market Performance
10.3.4 Seta Clinic Group Business Overview
10.3.5 Seta Clinic Group SWOT Analysis
10.3.6 Seta Clinic Group Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Immuno Cell Therapy Product Overview
10.4.3 Takeda Immuno Cell Therapy Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 SBI Holdings
10.5.1 SBI Holdings Basic Information
10.5.2 SBI Holdings Immuno Cell Therapy Product Overview
10.5.3 SBI Holdings Immuno Cell Therapy Product Market Performance
10.5.4 SBI Holdings Business Overview
10.5.5 SBI Holdings Recent Developments
10.6 Oxford BioTherapeutics
10.6.1 Oxford BioTherapeutics Basic Information
10.6.2 Oxford BioTherapeutics Immuno Cell Therapy Product Overview
10.6.3 Oxford BioTherapeutics Immuno Cell Therapy Product Market Performance
10.6.4 Oxford BioTherapeutics Business Overview
10.6.5 Oxford BioTherapeutics Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Basic Information
10.7.2 Fate Therapeutics Immuno Cell Therapy Product Overview
10.7.3 Fate Therapeutics Immuno Cell Therapy Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Immuno Cell Therapy Product Overview
10.8.3 Gilead Sciences Immuno Cell Therapy Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Immuno Cell Therapy Product Overview
10.9.3 Novartis Immuno Cell Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Osiris
10.10.1 Osiris Basic Information
10.10.2 Osiris Immuno Cell Therapy Product Overview
10.10.3 Osiris Immuno Cell Therapy Product Market Performance
10.10.4 Osiris Business Overview
10.10.5 Osiris Recent Developments
10.11 Vericel Corporation
10.11.1 Vericel Corporation Basic Information
10.11.2 Vericel Corporation Immuno Cell Therapy Product Overview
10.11.3 Vericel Corporation Immuno Cell Therapy Product Market Performance
10.11.4 Vericel Corporation Business Overview
10.11.5 Vericel Corporation Recent Developments
10.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Basic Information
10.12.2 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Overview
10.12.3 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Market Performance
10.12.4 Fujifilm Cellular Dynamics Business Overview
10.12.5 Fujifilm Cellular Dynamics Recent Developments
10.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Basic Information
10.13.2 JCR Pharmaceuticals Immuno Cell Therapy Product Overview
10.13.3 JCR Pharmaceuticals Immuno Cell Therapy Product Market Performance
10.13.4 JCR Pharmaceuticals Business Overview
10.13.5 JCR Pharmaceuticals Recent Developments
10.14 Beike Biotechnology
10.14.1 Beike Biotechnology Basic Information
10.14.2 Beike Biotechnology Immuno Cell Therapy Product Overview
10.14.3 Beike Biotechnology Immuno Cell Therapy Product Market Performance
10.14.4 Beike Biotechnology Business Overview
10.14.5 Beike Biotechnology Recent Developments
10.15 Golden Meditech
10.15.1 Golden Meditech Basic Information
10.15.2 Golden Meditech Immuno Cell Therapy Product Overview
10.15.3 Golden Meditech Immuno Cell Therapy Product Market Performance
10.15.4 Golden Meditech Business Overview
10.15.5 Golden Meditech Recent Developments
10.16 Guanhao Biotech
10.16.1 Guanhao Biotech Basic Information
10.16.2 Guanhao Biotech Immuno Cell Therapy Product Overview
10.16.3 Guanhao Biotech Immuno Cell Therapy Product Market Performance
10.16.4 Guanhao Biotech Business Overview
10.16.5 Guanhao Biotech Recent Developments
10.17 Beroni Group
10.17.1 Beroni Group Basic Information
10.17.2 Beroni Group Immuno Cell Therapy Product Overview
10.17.3 Beroni Group Immuno Cell Therapy Product Market Performance
10.17.4 Beroni Group Business Overview
10.17.5 Beroni Group Recent Developments
11 IMMUNO CELL THERAPY MARKET FORECAST BY REGION
11.1 Global Immuno Cell Therapy Market Size Forecast
11.2 Global Immuno Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno Cell Therapy Market Size Forecast by Region
11.2.4 South America Immuno Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immuno Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Immuno Cell Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Immuno Cell Therapy by Type (2026-2033)
12.1.2 Global Immuno Cell Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Immuno Cell Therapy by Type (2026-2033)
12.2 Global Immuno Cell Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Immuno Cell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immuno Cell Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immuno Cell Therapy
1.2 Key Market Segments
1.2.1 Immuno Cell Therapy Segment by Type
1.2.2 Immuno Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Immuno Cell Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Immuno Cell Therapy Product Life Cycle
3.3 Global Immuno Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immuno Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Immuno Cell Therapy Market Competitive Situation and Trends
3.8.1 Immuno Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IMMUNO CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immuno Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 IMMUNO CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immuno Cell Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Immuno Cell Therapy Price by Type (2020-2025)
7 IMMUNO CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno Cell Therapy Market Sales by Application (2020-2025)
7.3 Global Immuno Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
8 IMMUNO CELL THERAPY MARKET SALES BY REGION
8.1 Global Immuno Cell Therapy Sales by Region
8.1.1 Global Immuno Cell Therapy Sales by Region
8.1.2 Global Immuno Cell Therapy Sales Market Share by Region
8.2 Global Immuno Cell Therapy Market Size by Region
8.2.1 Global Immuno Cell Therapy Market Size by Region
8.2.2 Global Immuno Cell Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Immuno Cell Therapy Sales by Country
8.3.2 North America Immuno Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immuno Cell Therapy Sales by Country
8.4.2 Europe Immuno Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immuno Cell Therapy Sales by Region
8.5.2 Asia Pacific Immuno Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immuno Cell Therapy Sales by Country
8.6.2 South America Immuno Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immuno Cell Therapy Sales by Region
8.7.2 Middle East and Africa Immuno Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 IMMUNO CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Immuno Cell Therapy by Region(2020-2025)
9.2 Global Immuno Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immuno Cell Therapy Production
9.4.1 North America Immuno Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immuno Cell Therapy Production
9.5.1 Europe Immuno Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immuno Cell Therapy Production (2020-2025)
9.6.1 Japan Immuno Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immuno Cell Therapy Production (2020-2025)
9.7.1 China Immuno Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 MEDINET Co
10.1.1 MEDINET Co Basic Information
10.1.2 MEDINET Co Immuno Cell Therapy Product Overview
10.1.3 MEDINET Co Immuno Cell Therapy Product Market Performance
10.1.4 MEDINET Co Business Overview
10.1.5 MEDINET Co SWOT Analysis
10.1.6 MEDINET Co Recent Developments
10.2 Erytech
10.2.1 Erytech Basic Information
10.2.2 Erytech Immuno Cell Therapy Product Overview
10.2.3 Erytech Immuno Cell Therapy Product Market Performance
10.2.4 Erytech Business Overview
10.2.5 Erytech SWOT Analysis
10.2.6 Erytech Recent Developments
10.3 Seta Clinic Group
10.3.1 Seta Clinic Group Basic Information
10.3.2 Seta Clinic Group Immuno Cell Therapy Product Overview
10.3.3 Seta Clinic Group Immuno Cell Therapy Product Market Performance
10.3.4 Seta Clinic Group Business Overview
10.3.5 Seta Clinic Group SWOT Analysis
10.3.6 Seta Clinic Group Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Immuno Cell Therapy Product Overview
10.4.3 Takeda Immuno Cell Therapy Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 SBI Holdings
10.5.1 SBI Holdings Basic Information
10.5.2 SBI Holdings Immuno Cell Therapy Product Overview
10.5.3 SBI Holdings Immuno Cell Therapy Product Market Performance
10.5.4 SBI Holdings Business Overview
10.5.5 SBI Holdings Recent Developments
10.6 Oxford BioTherapeutics
10.6.1 Oxford BioTherapeutics Basic Information
10.6.2 Oxford BioTherapeutics Immuno Cell Therapy Product Overview
10.6.3 Oxford BioTherapeutics Immuno Cell Therapy Product Market Performance
10.6.4 Oxford BioTherapeutics Business Overview
10.6.5 Oxford BioTherapeutics Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Basic Information
10.7.2 Fate Therapeutics Immuno Cell Therapy Product Overview
10.7.3 Fate Therapeutics Immuno Cell Therapy Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Immuno Cell Therapy Product Overview
10.8.3 Gilead Sciences Immuno Cell Therapy Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Immuno Cell Therapy Product Overview
10.9.3 Novartis Immuno Cell Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Osiris
10.10.1 Osiris Basic Information
10.10.2 Osiris Immuno Cell Therapy Product Overview
10.10.3 Osiris Immuno Cell Therapy Product Market Performance
10.10.4 Osiris Business Overview
10.10.5 Osiris Recent Developments
10.11 Vericel Corporation
10.11.1 Vericel Corporation Basic Information
10.11.2 Vericel Corporation Immuno Cell Therapy Product Overview
10.11.3 Vericel Corporation Immuno Cell Therapy Product Market Performance
10.11.4 Vericel Corporation Business Overview
10.11.5 Vericel Corporation Recent Developments
10.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Basic Information
10.12.2 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Overview
10.12.3 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Market Performance
10.12.4 Fujifilm Cellular Dynamics Business Overview
10.12.5 Fujifilm Cellular Dynamics Recent Developments
10.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Basic Information
10.13.2 JCR Pharmaceuticals Immuno Cell Therapy Product Overview
10.13.3 JCR Pharmaceuticals Immuno Cell Therapy Product Market Performance
10.13.4 JCR Pharmaceuticals Business Overview
10.13.5 JCR Pharmaceuticals Recent Developments
10.14 Beike Biotechnology
10.14.1 Beike Biotechnology Basic Information
10.14.2 Beike Biotechnology Immuno Cell Therapy Product Overview
10.14.3 Beike Biotechnology Immuno Cell Therapy Product Market Performance
10.14.4 Beike Biotechnology Business Overview
10.14.5 Beike Biotechnology Recent Developments
10.15 Golden Meditech
10.15.1 Golden Meditech Basic Information
10.15.2 Golden Meditech Immuno Cell Therapy Product Overview
10.15.3 Golden Meditech Immuno Cell Therapy Product Market Performance
10.15.4 Golden Meditech Business Overview
10.15.5 Golden Meditech Recent Developments
10.16 Guanhao Biotech
10.16.1 Guanhao Biotech Basic Information
10.16.2 Guanhao Biotech Immuno Cell Therapy Product Overview
10.16.3 Guanhao Biotech Immuno Cell Therapy Product Market Performance
10.16.4 Guanhao Biotech Business Overview
10.16.5 Guanhao Biotech Recent Developments
10.17 Beroni Group
10.17.1 Beroni Group Basic Information
10.17.2 Beroni Group Immuno Cell Therapy Product Overview
10.17.3 Beroni Group Immuno Cell Therapy Product Market Performance
10.17.4 Beroni Group Business Overview
10.17.5 Beroni Group Recent Developments
11 IMMUNO CELL THERAPY MARKET FORECAST BY REGION
11.1 Global Immuno Cell Therapy Market Size Forecast
11.2 Global Immuno Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno Cell Therapy Market Size Forecast by Region
11.2.4 South America Immuno Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immuno Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Immuno Cell Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Immuno Cell Therapy by Type (2026-2033)
12.1.2 Global Immuno Cell Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Immuno Cell Therapy by Type (2026-2033)
12.2 Global Immuno Cell Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Immuno Cell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immuno Cell Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno Cell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Immuno Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Immuno Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Immuno Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Cell Therapy as of 2024)
Table 10. Global Market Immuno Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Immuno Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Immuno Cell Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Immuno Cell Therapy Sales by Type (K Units)
Table 26. Global Immuno Cell Therapy Market Size by Type (M USD)
Table 27. Global Immuno Cell Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Immuno Cell Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Immuno Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Immuno Cell Therapy Market Size Share by Type (2020-2025)
Table 31. Global Immuno Cell Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Immuno Cell Therapy Sales (K Units) by Application
Table 33. Global Immuno Cell Therapy Market Size by Application
Table 34. Global Immuno Cell Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Immuno Cell Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Immuno Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Immuno Cell Therapy Market Share by Application (2020-2025)
Table 38. Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Immuno Cell Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Immuno Cell Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Immuno Cell Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Immuno Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Immuno Cell Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. MEDINET Co Basic Information
Table 62. MEDINET Co Immuno Cell Therapy Product Overview
Table 63. MEDINET Co Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. MEDINET Co Business Overview
Table 65. MEDINET Co SWOT Analysis
Table 66. MEDINET Co Recent Developments
Table 67. Erytech Basic Information
Table 68. Erytech Immuno Cell Therapy Product Overview
Table 69. Erytech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Erytech Business Overview
Table 71. Erytech SWOT Analysis
Table 72. Erytech Recent Developments
Table 73. Seta Clinic Group Basic Information
Table 74. Seta Clinic Group Immuno Cell Therapy Product Overview
Table 75. Seta Clinic Group Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Seta Clinic Group Business Overview
Table 77. Seta Clinic Group SWOT Analysis
Table 78. Seta Clinic Group Recent Developments
Table 79. Takeda Basic Information
Table 80. Takeda Immuno Cell Therapy Product Overview
Table 81. Takeda Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Takeda Business Overview
Table 83. Takeda Recent Developments
Table 84. SBI Holdings Basic Information
Table 85. SBI Holdings Immuno Cell Therapy Product Overview
Table 86. SBI Holdings Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. SBI Holdings Business Overview
Table 88. SBI Holdings Recent Developments
Table 89. Oxford BioTherapeutics Basic Information
Table 90. Oxford BioTherapeutics Immuno Cell Therapy Product Overview
Table 91. Oxford BioTherapeutics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Oxford BioTherapeutics Business Overview
Table 93. Oxford BioTherapeutics Recent Developments
Table 94. Fate Therapeutics Basic Information
Table 95. Fate Therapeutics Immuno Cell Therapy Product Overview
Table 96. Fate Therapeutics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Fate Therapeutics Business Overview
Table 98. Fate Therapeutics Recent Developments
Table 99. Gilead Sciences Basic Information
Table 100. Gilead Sciences Immuno Cell Therapy Product Overview
Table 101. Gilead Sciences Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Gilead Sciences Business Overview
Table 103. Gilead Sciences Recent Developments
Table 104. Novartis Basic Information
Table 105. Novartis Immuno Cell Therapy Product Overview
Table 106. Novartis Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Osiris Basic Information
Table 110. Osiris Immuno Cell Therapy Product Overview
Table 111. Osiris Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Osiris Business Overview
Table 113. Osiris Recent Developments
Table 114. Vericel Corporation Basic Information
Table 115. Vericel Corporation Immuno Cell Therapy Product Overview
Table 116. Vericel Corporation Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Vericel Corporation Business Overview
Table 118. Vericel Corporation Recent Developments
Table 119. Fujifilm Cellular Dynamics Basic Information
Table 120. Fujifilm Cellular Dynamics Immuno Cell Therapy Product Overview
Table 121. Fujifilm Cellular Dynamics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Fujifilm Cellular Dynamics Business Overview
Table 123. Fujifilm Cellular Dynamics Recent Developments
Table 124. JCR Pharmaceuticals Basic Information
Table 125. JCR Pharmaceuticals Immuno Cell Therapy Product Overview
Table 126. JCR Pharmaceuticals Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. JCR Pharmaceuticals Business Overview
Table 128. JCR Pharmaceuticals Recent Developments
Table 129. Beike Biotechnology Basic Information
Table 130. Beike Biotechnology Immuno Cell Therapy Product Overview
Table 131. Beike Biotechnology Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Beike Biotechnology Business Overview
Table 133. Beike Biotechnology Recent Developments
Table 134. Golden Meditech Basic Information
Table 135. Golden Meditech Immuno Cell Therapy Product Overview
Table 136. Golden Meditech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Golden Meditech Business Overview
Table 138. Golden Meditech Recent Developments
Table 139. Guanhao Biotech Basic Information
Table 140. Guanhao Biotech Immuno Cell Therapy Product Overview
Table 141. Guanhao Biotech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Guanhao Biotech Business Overview
Table 143. Guanhao Biotech Recent Developments
Table 144. Beroni Group Basic Information
Table 145. Beroni Group Immuno Cell Therapy Product Overview
Table 146. Beroni Group Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Beroni Group Business Overview
Table 148. Beroni Group Recent Developments
Table 149. Global Immuno Cell Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Global Immuno Cell Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 152. North America Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 154. Europe Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Immuno Cell Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 156. Asia Pacific Immuno Cell Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 158. South America Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Immuno Cell Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 162. Global Immuno Cell Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Immuno Cell Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 164. Global Immuno Cell Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 165. Global Immuno Cell Therapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno Cell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Immuno Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Immuno Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Immuno Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Cell Therapy as of 2024)
Table 10. Global Market Immuno Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Immuno Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Immuno Cell Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Immuno Cell Therapy Sales by Type (K Units)
Table 26. Global Immuno Cell Therapy Market Size by Type (M USD)
Table 27. Global Immuno Cell Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Immuno Cell Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Immuno Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Immuno Cell Therapy Market Size Share by Type (2020-2025)
Table 31. Global Immuno Cell Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Immuno Cell Therapy Sales (K Units) by Application
Table 33. Global Immuno Cell Therapy Market Size by Application
Table 34. Global Immuno Cell Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Immuno Cell Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Immuno Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Immuno Cell Therapy Market Share by Application (2020-2025)
Table 38. Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Immuno Cell Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Immuno Cell Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Immuno Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Immuno Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Immuno Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Immuno Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Immuno Cell Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Immuno Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Immuno Cell Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Immuno Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. MEDINET Co Basic Information
Table 62. MEDINET Co Immuno Cell Therapy Product Overview
Table 63. MEDINET Co Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. MEDINET Co Business Overview
Table 65. MEDINET Co SWOT Analysis
Table 66. MEDINET Co Recent Developments
Table 67. Erytech Basic Information
Table 68. Erytech Immuno Cell Therapy Product Overview
Table 69. Erytech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Erytech Business Overview
Table 71. Erytech SWOT Analysis
Table 72. Erytech Recent Developments
Table 73. Seta Clinic Group Basic Information
Table 74. Seta Clinic Group Immuno Cell Therapy Product Overview
Table 75. Seta Clinic Group Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Seta Clinic Group Business Overview
Table 77. Seta Clinic Group SWOT Analysis
Table 78. Seta Clinic Group Recent Developments
Table 79. Takeda Basic Information
Table 80. Takeda Immuno Cell Therapy Product Overview
Table 81. Takeda Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Takeda Business Overview
Table 83. Takeda Recent Developments
Table 84. SBI Holdings Basic Information
Table 85. SBI Holdings Immuno Cell Therapy Product Overview
Table 86. SBI Holdings Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. SBI Holdings Business Overview
Table 88. SBI Holdings Recent Developments
Table 89. Oxford BioTherapeutics Basic Information
Table 90. Oxford BioTherapeutics Immuno Cell Therapy Product Overview
Table 91. Oxford BioTherapeutics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Oxford BioTherapeutics Business Overview
Table 93. Oxford BioTherapeutics Recent Developments
Table 94. Fate Therapeutics Basic Information
Table 95. Fate Therapeutics Immuno Cell Therapy Product Overview
Table 96. Fate Therapeutics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Fate Therapeutics Business Overview
Table 98. Fate Therapeutics Recent Developments
Table 99. Gilead Sciences Basic Information
Table 100. Gilead Sciences Immuno Cell Therapy Product Overview
Table 101. Gilead Sciences Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Gilead Sciences Business Overview
Table 103. Gilead Sciences Recent Developments
Table 104. Novartis Basic Information
Table 105. Novartis Immuno Cell Therapy Product Overview
Table 106. Novartis Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Osiris Basic Information
Table 110. Osiris Immuno Cell Therapy Product Overview
Table 111. Osiris Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Osiris Business Overview
Table 113. Osiris Recent Developments
Table 114. Vericel Corporation Basic Information
Table 115. Vericel Corporation Immuno Cell Therapy Product Overview
Table 116. Vericel Corporation Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Vericel Corporation Business Overview
Table 118. Vericel Corporation Recent Developments
Table 119. Fujifilm Cellular Dynamics Basic Information
Table 120. Fujifilm Cellular Dynamics Immuno Cell Therapy Product Overview
Table 121. Fujifilm Cellular Dynamics Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Fujifilm Cellular Dynamics Business Overview
Table 123. Fujifilm Cellular Dynamics Recent Developments
Table 124. JCR Pharmaceuticals Basic Information
Table 125. JCR Pharmaceuticals Immuno Cell Therapy Product Overview
Table 126. JCR Pharmaceuticals Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. JCR Pharmaceuticals Business Overview
Table 128. JCR Pharmaceuticals Recent Developments
Table 129. Beike Biotechnology Basic Information
Table 130. Beike Biotechnology Immuno Cell Therapy Product Overview
Table 131. Beike Biotechnology Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Beike Biotechnology Business Overview
Table 133. Beike Biotechnology Recent Developments
Table 134. Golden Meditech Basic Information
Table 135. Golden Meditech Immuno Cell Therapy Product Overview
Table 136. Golden Meditech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Golden Meditech Business Overview
Table 138. Golden Meditech Recent Developments
Table 139. Guanhao Biotech Basic Information
Table 140. Guanhao Biotech Immuno Cell Therapy Product Overview
Table 141. Guanhao Biotech Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Guanhao Biotech Business Overview
Table 143. Guanhao Biotech Recent Developments
Table 144. Beroni Group Basic Information
Table 145. Beroni Group Immuno Cell Therapy Product Overview
Table 146. Beroni Group Immuno Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Beroni Group Business Overview
Table 148. Beroni Group Recent Developments
Table 149. Global Immuno Cell Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Global Immuno Cell Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 152. North America Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 154. Europe Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Immuno Cell Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 156. Asia Pacific Immuno Cell Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 158. South America Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Immuno Cell Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Immuno Cell Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Immuno Cell Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 162. Global Immuno Cell Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Immuno Cell Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 164. Global Immuno Cell Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 165. Global Immuno Cell Therapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immuno Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno Cell Therapy Market Size (M USD), 2024-2033
Figure 5. Global Immuno Cell Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Immuno Cell Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immuno Cell Therapy Product Life Cycle
Figure 13. Immuno Cell Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Immuno Cell Therapy Revenue Share by Manufacturers in 2024
Figure 15. Immuno Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Immuno Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immuno Cell Therapy Revenue in 2024
Figure 18. Industry Chain Map of Immuno Cell Therapy
Figure 19. Global Immuno Cell Therapy Market PEST Analysis
Figure 20. Global Immuno Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immuno Cell Therapy Market Share by Type
Figure 27. Sales Market Share of Immuno Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immuno Cell Therapy by Type in 2024
Figure 29. Market Size Share of Immuno Cell Therapy by Type (2020-2025)
Figure 30. Market Size Share of Immuno Cell Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immuno Cell Therapy Market Share by Application
Figure 33. Global Immuno Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immuno Cell Therapy Sales Market Share by Application in 2024
Figure 35. Global Immuno Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global Immuno Cell Therapy Market Share by Application in 2024
Figure 37. Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immuno Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immuno Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immuno Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Immuno Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immuno Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immuno Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Immuno Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immuno Cell Therapy Market Size Market Share by Region in 2024
Figure 68. China Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America Immuno Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Immuno Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immuno Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immuno Cell Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immuno Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Immuno Cell Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Immuno Cell Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Immuno Cell Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Immuno Cell Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Immuno Cell Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Immuno Cell Therapy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Immuno Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno Cell Therapy Market Size (M USD), 2024-2033
Figure 5. Global Immuno Cell Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Immuno Cell Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immuno Cell Therapy Product Life Cycle
Figure 13. Immuno Cell Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Immuno Cell Therapy Revenue Share by Manufacturers in 2024
Figure 15. Immuno Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Immuno Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immuno Cell Therapy Revenue in 2024
Figure 18. Industry Chain Map of Immuno Cell Therapy
Figure 19. Global Immuno Cell Therapy Market PEST Analysis
Figure 20. Global Immuno Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immuno Cell Therapy Market Share by Type
Figure 27. Sales Market Share of Immuno Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Immuno Cell Therapy by Type in 2024
Figure 29. Market Size Share of Immuno Cell Therapy by Type (2020-2025)
Figure 30. Market Size Share of Immuno Cell Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immuno Cell Therapy Market Share by Application
Figure 33. Global Immuno Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Immuno Cell Therapy Sales Market Share by Application in 2024
Figure 35. Global Immuno Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global Immuno Cell Therapy Market Share by Application in 2024
Figure 37. Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immuno Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Immuno Cell Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immuno Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Immuno Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immuno Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immuno Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Immuno Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immuno Cell Therapy Market Size Market Share by Region in 2024
Figure 68. China Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Immuno Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America Immuno Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Immuno Cell Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immuno Cell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Immuno Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immuno Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immuno Cell Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immuno Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Immuno Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immuno Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Immuno Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Immuno Cell Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Immuno Cell Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Immuno Cell Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Immuno Cell Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Immuno Cell Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Immuno Cell Therapy Market Share Forecast by Application (2026-2033)
